Profound Medical Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on July 16, 2026. The filing serves as a Regulation FD disclosure to announce the upcoming release of the Company's second quarter financial results.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding the timing of the financial report rather than a financial statement itself.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely communicates the schedule for the upcoming earnings release.
Guidance, Outlook, and Management Commentary
Management has announced the following schedule for the second quarter 2026 results:
- Earnings Release Date: Thursday, August 6, 2026, after market close.
- Conference Call: Scheduled for 4:30 p.m. Eastern Time on August 6, 2026, to review results and discuss business developments.
- Access: Details for the conference call and webcast are contained in the press release furnished as Exhibit 99.1.
The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other SEC filings.
Investor Verification Checklist
- Verify the exact time of the earnings release on August 6, 2026, via the Company's investor relations website or the press release (Exhibit 99.1).
- Confirm the dial-in details and webcast link for the 4:30 p.m. ET conference call.
- Review the actual Q2 2026 financial statements once released to obtain revenue, profit, and cash flow data, as these are absent from this 8-K.